Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-073831
Filing Date
2020-06-16
Accepted
2020-06-16 17:16:26
Documents
1
Period of Report
2020-06-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2022528d1_4.html 4  
1 OWNERSHIP DOCUMENT tm2022528d1_4.xml 4 3934
  Complete submission text file 0001104659-20-073831.txt   5571
Mailing Address C/O IBIO, INC. 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address
Kay Robert (Reporting) CIK: 0001285612 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 20967296

Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations